FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)Business Wire • 02/10/23
Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers second sales milestone payment to Basilea from PfizerGlobeNewsWire • 02/07/23
Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)Benzinga • 02/03/23
Moderna's stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023Market Watch • 01/31/23